Gelman (US) and B Braun Melsungen (Germany) collaborate on filters:
This article was originally published in Clinica
Gelman (US) and B Braun Melsungen (Germany) are to collaborate on the development of medical filtration products. B Braun will buy a minimum of $5 million worth of Gelman filters as part of the deal.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.